FDA panel suggests first epilepsy drug that is cannabis-derived a prescription that is new manufactured by UK-based GW Pharmaceuticals PLC could be the initial prescription that is cannabis-based become authorized by the usa Food and Drug Administration. A food and drug administration panel that is advisory the agency’s approval of this cannabis-derived Epidiolex for the treating uncommon kinds of epilepsy. The committee voted 13-0 meant for Epidiolex after determining that the drug’s risk-benefit profile ended...